Skip to main content
Fig. 1 | Orphanet Journal of Rare Diseases

Fig. 1

From: Clinical symptoms, biochemistry, and liver histology during the native liver period of progressive familial intrahepatic cholestasis type 2

Fig. 1

Period of follow-up, native liver survival, and survival of Japanese PFIC2 patients. A Flowchart of patient inclusion in this study. B The follow-up period of the Japanese PFIC2 patients. The patients without NaPB treatment and with NaPB treatment are shown in the gray and blue bars, respectively. C Native liver survival period of the Japanese PFIC2 patients. D Survival period of the Japanese PFIC2 patients. LDLT, living donor liver transplantation; NaPB, sodium 4-phenylbutyrate

Back to article page

Orphanet Journal of Rare Diseases

ISSN: 1750-1172